OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Clinical trials for OLIGOMETASTATIC PROSTATE CANCER (OMPC) explained in plain language.
Never miss a new study
Get alerted when new OLIGOMETASTATIC PROSTATE CANCER (OMPC) trials appear
Sign up with your email to follow new studies for OLIGOMETASTATIC PROSTATE CANCER (OMPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental DNA vaccine aims to train immune system against prostate cancer
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase trial tests whether an experimental DNA vaccine (pTVG-HP) combined with the immunotherapy drug nivolumab and targeted radiation can help the immune system attack prostate cancer that has returned in a few spots. The study involves 14 men whose cancer has come bac…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 02:06 UTC
-
New radiation therapy could delay prostate cancer return without hormone drugs
Disease control Recruiting nowThis study tests a radioactive drug (177Lu-PSMA-617) in men whose prostate cancer has returned in a few spots after initial treatment. The goal is to see if the drug can delay cancer spread and the need for hormone therapy, which often causes side effects. About 450 men will be r…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:02 UTC